Outset Medical, Inc.
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$4M
Investors
13
Min Invest
None stated
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
Outset Medical, Inc. is a Delaware corporation that filed a Form D with the SEC on January 21, 2025 in the Other Health Care industry group. The offering claims Rule 506(b) and covers equity. Outset Medical, Inc. reported $3,886,400 sold from 13 investors of a $3,886,400 total offering as of the Form D filed January 21, 2025. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports 3 non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 3052 Orchard Drive, San Jose, CA 95134.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
1
latest Jan 21, 2025
Critical / warning
0 / 0
0 watch · 1 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
5
closed, lapsed
Latest event New filer · Jan 21, 2025
SEC.govFund family Beneficially owned by BANK OF AMERICA CORP /DE/ · full family and the filing behind each link in the terminal
Investor
- The full fund family and 1 related vehicle (parallel, feeder, successor, sibling series) with the filing that shows each link
- 1 filing event with values and deltas, latest 2025-01-21, and alerts on the next one
- 5 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2025-01-21: 7 related persons added and 5 removed against the filing of 2020-02-07; 10 now listed. The names are in the Terminal feed.
Leslie Trigg
Director · San Jose, CA
Keith Grossman
Director · San Jose, CA
Brent Lang
Director · San Jose, CA
Andrea Saia
Director · San Jose, CA
Dale Jones
Director · San Jose, CA
Nabeel Ahmed
Executive Officer · San Jose, CA
Patrick T. Hackett
Director · San Jose, CA
Karen T. Drexler
Director · San Jose, CA
John T. Brottem
Executive Officer · San Jose, CA
Marc T. Nash
Executive Officer · San Jose, CA
Questions About Outset Medical, Inc.
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is Outset Medical, Inc.?
Outset Medical, Inc. is a Delaware corporation that filed a Form D with the SEC on January 21, 2025 in the Other Health Care industry group. The filing claims Rule 506(b) for an offering of equity.
Is Outset Medical, Inc. legit?
AltStreet does not rate legitimacy; it reports the public record. Outset Medical, Inc. filed a Form D with the SEC on January 21, 2025 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $3,886,400 sold to 13 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is Outset Medical, Inc. registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Outset Medical, Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has Outset Medical, Inc. raised?
Outset Medical, Inc. reported $3,886,400 sold from 13 investors of a $3,886,400 total offering as of the Form D filed January 21, 2025.
Who can invest in Outset Medical, Inc.?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports 3 non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.
What is the minimum investment in Outset Medical, Inc.?
The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.
Who is selling Outset Medical, Inc. and how are they paid?
The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.
Who is behind Outset Medical, Inc.?
The Form D lists 10 related persons: Leslie Trigg, director; Keith Grossman, director; Brent Lang, director; Andrea Saia, director; Dale Jones, director; Nabeel Ahmed, executive officer; Patrick T. Hackett, director; Karen T. Drexler, director, and 2 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is Outset Medical, Inc. located?
The issuer's address on its SEC filings is 3052 Orchard Drive, San Jose, CA 95134. Its phone number of record is 669-231-8200. It is organized under the laws of Delaware.
How long is the Outset Medical, Inc. offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.
What is Outset Medical, Inc.'s revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.

Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
